
Venture Capital & Emerging Companies
Viewpoints
Filter by:
Extending for Success: The Rising Trend of Extension Rounds and the Importance of Due Diligence
January 11, 2023 | Article | By Jeremy Glaser, Roman M. Gorokhov, Will Perkins
MintzTech Connect Industry News: Spotlight on Ben Zises and SuperAngel.Fund
December 7, 2022 | Article | By Daniel DeWolf
MintzTech Connect: All Things Technology — December 2022
December 7, 2022 | Article | By Daniel DeWolf, Samuel Asher Effron
OpEd: Top Five Ways to Accelerate Growth of Emerging Companies
October 21, 2022 | Blog
Mintz Leads For Axoft In $8 Million Seed Round Demonstrating Continued Dedication To Biotech Start-Up Market
October 19, 2022
Mintz represented Axoft, a neurotechnology company, in its $8 million seed round led by The Engine, a venture firm spun out of MIT that invests in early-stage Tough Tech companies.
MintzTech Connect Industry News: Spotlight on Adgile Media Group
September 19, 2022 | Article | By Daniel DeWolf
MintzTech Connect Industry News: Spotlight on Radicle Science
September 19, 2022 | Article | By Jeremy Glaser
MintzTech Connect: All Things Technology — September 2022
September 19, 2022 | Article | By Daniel DeWolf, Samuel Asher Effron
Mintz Venture Watch — Volume 3: A Report on Deal Trends from Q1 and Q2 2022
August 17, 2022 | Article | By Daniel DeWolf, Lewis Geffen, Jeremy Glaser
Amendment to Delaware Law Permits Exculpation of Officers in Corporate Charters
August 15, 2022 | Advisory | By Daniel A. Lerner, John M. Monts
Is a Public Benefit Corporation Right for Your Mission-Driven Business?
July 18, 2022 | Article | By Kati P. Strzelczyk
Read an analysis of the differences between public benefit corporations and traditional corporations and issues for founders of mission-driven business to consider when deciding on a corporate structure.
Read more
MintzTech Connect: All Things Technology — May 2022
May 25, 2022 | Article | By Daniel DeWolf, Samuel Asher Effron
MintzTech Connect Industry News: Spotlight on YUR Inc.
May 25, 2022 | Article | By Daniel DeWolf, Samuel Asher Effron
Six Common Contract Traps: A Field Guide
March 25, 2022 | Advisory | By Alex Civetta
Financing Options for Life Sciences Companies in 2022
March 21, 2022 | Blog
Public and private life science companies have multiple options available for capital-raising. Here are a few to be considered.
Read more
Mintz Venture Watch — Volume 2: A Report on Deal Trends from Q3 and Q4 2021
February 9, 2022 | Article | By Daniel DeWolf, Lewis Geffen, Jeremy Glaser
MintzTech Connect Industry News: Spotlight on Miyoko’s Creamery
December 10, 2021 | Article | By Stephen Osborn
This edition of MintzTech Connect covers the patentability of blockchain and cryptocurrency, SEC Rule 148, a Delaware Supreme Court ruling on the advance waiver of appraisal rights, and Miyoko’s Creamery.
Read more
MintzTech Connect: All Things Technology — December 2021
December 10, 2021 | Article | By Daniel DeWolf, Samuel Asher Effron
This edition covers the patentability of blockchain and cryptocurrency, SEC Rule 148, a Delaware Supreme Court ruling on the advance waiver of appraisal rights, and Miyoko’s Creamery.
Read more
Delaware Supreme Court Upholds Advance Waiver of Statutory Appraisal Rights — Affirms Key Component of “Drag Along” Critical for M&A Exits for Venture-Backed Companies
November 23, 2021 | Alert | By Matthew Gardella, Brendan J. Chaisson
This alert discusses the Delaware Supreme Court’s decision in Manti Holdings v. Authentix Acquisition Co. that upheld the enforceability of an advance waiver of statutory appraisal rights by common stockholders.
Read more
Mintz Venture Watch — Volume 1: A Report on Deal Trends from Q1 and Q2 2021
August 10, 2021 | Article | By Daniel DeWolf, Lewis Geffen, Jeremy Glaser
Venture capital investing continues to thrive across all sectors. During the first half of 2021, the Mintz team advised more than 65 emerging companies and investors in transactions in all facets of the life sciences, technology, and energy and sustainability industries.
Read more
Explore Other Viewpoints:
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Cross-Border Asset Recovery
- Debt Financing
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment, Labor & Benefits
- Energy & Sustainability
- Environmental Enforcement Defense
- Environmental Law
- FDA Regulatory
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations